## CCEP: Coca-Cola Europacific Partners PLC - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 1.49 indicates fundamental undervaluation. Quality metrics strong (ROE 18%). Caution: momentum weakening (-4.1% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($88.67)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Coca-Cola Europacific Partners completes €1 billion share buyback**
- Source: Investing.com | 20251222T120946 | Bullish | Relevance: 100%
- Coca-Cola Europacific Partners (CCEP) announced the completion of its €1 billion share buyback program, which began earlier this year. The company repurchased over 12.7 million ordinary shares, returning nearly €1 billion to shareholders. This program, initiated on February 14, 2025, involved share acquisitions on both US and London trading venues.

**2. Coca-Cola Europacific Partners completes €1 billion share buyback program By Investing.com**
- Source: Investing.com South Africa | 20251223T170916 | Bullish | Relevance: 100%
- Coca-Cola Europacific Partners (NASDAQ: CCEP) has announced the completion of its €1 billion share buyback program, launched on February 14, 2025. The company repurchased 12,718,173 ordinary shares through transactions on both US and London trading venues, returning nearly €1 billion to shareholders. These repurchased shares are slated for cancellation.

**3. Coca-Cola Europacific Partners Executive Sells 2,000 Shares on Nasdaq**
- Source: TipRanks | 20251223T160916 | Somewhat-Bearish | Relevance: 100%
- Veronique Vuillod, Chief People and Culture Officer at Coca-Cola Europacific Partners (CCEP), sold 2,000 ordinary shares on December 22, 2025, for approximately $184,580 on the Nasdaq Stock Market. This transaction was disclosed under insider trading regulations. Coca-Cola Europacific Partners is a major bottler and distributor for Coca-Cola products across Europe and the Asia-Pacific region.

**4. Coca-Cola Europacific Partners Executives Acquire Shares Under UK Plans**
- Source: TipRanks | 20251223T140916 | Somewhat-Bullish | Relevance: 100%
- Numerous senior executives at Coca-Cola Europacific Partners (CCEP) have acquired fractional ordinary shares under the company's UK Share Plan and UK Shareshop, with transactions executed on December 19, 2025. These modest acquisitions by leaders like CFO Edward Walker and General Counsel Clare Wardle reinforce alignment between management's incentives and shareholder interests. This move highlights CCEP's commitment to standard governance and transparency practices as a London-headquartered, U.S.-listed multinational bottler.

**5. Completion of Share Buyback Programme**
- Source: Actusnews | 20251222T120946 | Somewhat-Bullish | Relevance: 100%
- Coca-Cola Europacific Partners plc announced the completion of its share buyback programme, which aimed to purchase up to EUR 1 billion of the Company's ordinary shares. The Company repurchased 12,718,173 ordinary shares for an aggregate consideration of approximately EUR 999,998,769.23, effectively returning this amount to its shareholders. The programme was initially announced on February 14, 2025.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 16.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 1 |

**Top Holders:**
- Invesco Ltd.: 3.5% (+31.6%)
- Blackrock Inc.: 3.4% (-1.3%)
- Vanguard Group Inc: 2.4% (+2.6%)
- Goldman Sachs Group : 1.5% (+6.9%)
- Boston Partners: 1.4% (+2.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Share repurchase program provides demand floor and EPS support.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.49 suggests fair value with growth premium. Forward P/E 20.6x stretched relative to 9% growth. Institutional flow bullish (8 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $41.7B |
| Beta | 0.38 |
| 52W Range | $73.40 - $100.67 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.49 |
| Forward P/E | 20.6 |
| Current P/E | 22.4 |
| YoY Growth | 8.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.5% to -0.7% (-4.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.7pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 53. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.65% (CS: 47) | Neutral |
| RSI_14 | 53.3 | Neutral |
| MACD Histogram | 0.06 | Bullish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 1.010x | Above |
| vs SMA200 | 1.013x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $91.57
- **Stop Loss:** $88.67 (3.2% risk)
- **Target:** $97.37 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 206
- **Position Value:** $18,863.42
- **Portfolio %:** 18.86%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-17 (Est: $0.00)

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*